Literature DB >> 15456940

The splicing regulatory protein p18SRP is down-regulated in Alzheimer's disease brain.

Klaus Heese1, Masako Fujita, Hiroyasu Akatsu, Takayuki Yamamoto, Kenji Kosaka, Yasuo Nagai, Tohru Sawada.   

Abstract

Alzheimer's disease (AD) is the most common neurodegenerative disorder of aging, accounting for an estimated two-thirds of all cases of senile dementia. Using bioinformatics, the yeast two-hybrid-system, reverse transcription polymerase chain reaction, and fluorescence microscopy analysis, we demonstrate here that the new putative splicing regulatory protein p18SRP is a lysine-rich zinc finger domain-containing protein that interacts with the serine-arginine (SR)-rich splicing regulatory protein SRrp86. The additional finding of its down-regulation in the brain of AD subjects points to a possible pivotal role of p18SRP in the control of cellular survival.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15456940     DOI: 10.1385/JMN:24:2:269

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  11 in total

1.  Regulation of alternative splicing by SRrp86 through coactivation and repression of specific SR proteins.

Authors:  Daron C Barnard; Jun Li; Rui Peng; James G Patton
Journal:  RNA       Date:  2002-04       Impact factor: 4.942

Review 2.  Pre-mRNA splicing and human disease.

Authors:  Nuno André Faustino; Thomas A Cooper
Journal:  Genes Dev       Date:  2003-02-15       Impact factor: 11.361

Review 3.  Alzheimer's disease: genes, proteins, and therapy.

Authors:  D J Selkoe
Journal:  Physiol Rev       Date:  2001-04       Impact factor: 37.312

4.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease.

Authors:  S S Mirra; A Heyman; D McKeel; S M Sumi; B J Crain; L M Brownlee; F S Vogel; J P Hughes; G van Belle; L Berg
Journal:  Neurology       Date:  1991-04       Impact factor: 9.910

5.  Targeted disruption of an essential vertebrate gene: ASF/SF2 is required for cell viability.

Authors:  J Wang; Y Takagaki; J L Manley
Journal:  Genes Dev       Date:  1996-10-15       Impact factor: 11.361

6.  Subtype analysis of neuropathologically diagnosed patients in a Japanese geriatric hospital.

Authors:  Hiroyasu Akatsu; Mitsuo Takahashi; Noriyuki Matsukawa; Yasushige Ishikawa; Naoki Kondo; Tomoo Sato; Hideka Nakazawa; Tatsuo Yamada; Hidechika Okada; Takayuki Yamamoto; Kenji Kosaka
Journal:  J Neurol Sci       Date:  2002-04-15       Impact factor: 3.181

Review 7.  Neuropathological stageing of Alzheimer-related changes.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

8.  Novel tau polymorphisms, tau haplotypes, and splicing in familial and sporadic frontotemporal dementia.

Authors:  Maria-Jesús Sobrido; Bruce L Miller; Necat Havlioglu; Victoria Zhukareva; Zhihong Jiang; Ziad S Nasreddine; Virginia M-Y Lee; Tiffany W Chow; Kirk C Wilhelmsen; Jeffrey L Cummings; Jane Y Wu; Daniel H Geschwind
Journal:  Arch Neurol       Date:  2003-05

9.  A unique glutamic acid-lysine (EK) domain acts as a splicing inhibitor.

Authors:  Jun Li; Daron C Barnard; James G Patton
Journal:  J Biol Chem       Date:  2002-08-14       Impact factor: 5.157

Review 10.  Multiple roles of the SR protein family in splicing regulation.

Authors:  J R Sanford; D Longman; J F Cáceres
Journal:  Prog Mol Subcell Biol       Date:  2003
View more
  2 in total

Review 1.  Genome-wide analysis of CCHC-type zinc finger (ZCCHC) proteins in yeast, Arabidopsis, and humans.

Authors:  Uri Aceituno-Valenzuela; Rosa Micol-Ponce; María Rosa Ponce
Journal:  Cell Mol Life Sci       Date:  2020-04-18       Impact factor: 9.261

2.  Reduced expression of SET7/9, a histone mono-methyltransferase, is associated with gastric cancer progression.

Authors:  Yoshimitsu Akiyama; Yuki Koda; Sun-Ju Byeon; Shu Shimada; Taketo Nishikawaji; Ayuna Sakamoto; Yingxuan Chen; Kazuyuki Kojima; Tatsuyuki Kawano; Yoshinobu Eishi; Dajun Deng; Woo Ho Kim; Wei-Guo Zhu; Yasuhito Yuasa; Shinji Tanaka
Journal:  Oncotarget       Date:  2016-01-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.